The partners signed a CRADA to develop biomarkers discovered by the Center for Prostate Disease Research for use in clinical diagnostic testing.
The deal expands one reached in 2013 to discover and develop therapeutic agents targeting cancer genome alterations.
The partners will work to establish Centrum Badan as the preferred testing partner for the NGS-based test in Poland, which had 376,000 live births last year.
The firm is now consulting with experts to evaluate detection of enteroviruses and rhinoviruses in respiratory specimens for its next-generation ePlex system.
The NextSeq CN500 sequencer was developed in collaboration with Illumina to offer clinical non-invasive prenatal testing for the Chinese market.
In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.
George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.
A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.
The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.